Stem cell research

Brain confetti - why our sense of smell declines when we get old

As mammals age, their sense of smell deteriorates. In a study published in the journal ‘Cell Reports’, an interdisciplinary research team at Helmholtz Zentrum München and the University Medical Centre Mainz investigated why this is the case.

© Helmholtz Zentrum München

For their study, the researchers tracked the development of stem cells in the brains of mice using what are known as confetti reporters. They then analysed the complex data obtained using intelligent algorithms.

In mammals, generation of new neurons (neurogenesis) is mainly limited to early childhood and occurs in adulthood only in a few regions of the forebrain. One such exception is olfactory neurons, which develop from stem cells via several intermediate stages. “The production of these neurons diminishes with advancing age. In our recent study we wanted to find out the cellular basis and what role stem cells play in the process,” says Dr. Carsten Marr, explaining the approach. He is a research group leader at the Institute of Computational Biology (ICB) of Helmholtz Zentrum München. 

confetti reporter cells
The researchers tracked the development of stem cells using so-called confetti reporters.
Source: © Helmholtz Zentrum München

To shed light on this question, an interdisciplinary team of experts from the Helmholtz Zentrum München was formed that included the mathematicians Lisa Bast and Carsten Marr as well as stem cell researchers Dr. Filippo Calzolari (now Institute of Physiological Chemistry at the University Mainz) and Professor Jovica Ninkovic. “Our approach utilised what are known as confetti reporters to perform lineage tracing: In mouse brains, we induced individual stem cells and all their descendants – called clones − to light up in a specific colour”, says Filippo Calzolari. In this way, the scientists could distinguish clones over time by the different colours that give the technique its name. “In the next step, we compared clones found in young and older mice to find out what contribution individual stem cells and intermediates make to the neurogenesis of mature olfactory cells”, Calzolari adds.

Connect the dots

Fewer cells differentiate into olfactory cells in old age as they tend to remain in the stem cell pool and become less active

Jovica Ninkovic

However, systematic analysis of these images proved nearly impossible for humans, in that the available data were extremely heterogeneous, making a comparison of young and old brains difficult. Here the expertise of Carsten Marr and his team came into play. They are specialists in the quantification of single-cell dynamics, i.e. the study of which and how many cells of a large population make which cell fate decisions. To do so, the researchers use artificial intelligence methods, develop mathematical models and deduce algorithms to help analyse the image data.

“We compared the confetti measurements with several mathematical models of neurogenesis,” explains Lisa Bast. “We found that the ability of self-renewal declines in old age, especially in certain intermediate stages called transit amplifying progenitors.” In addition, the analysis showed that asymmetric cell division and quiescence of stem cells increased in older mice. “That means that fewer cells differentiate into olfactory cells in old age as they tend to remain in the stem cell pool and become less active. Therefore, the production comes to a halt”, says Jovica Ninkovic. The work is the first in which scientists have been able to quantitatively describe the behaviour of neural stem cells in the living mammalian brain using a mathematical model.


Source: Helmholtz Zentrum München

19.12.2018

Read all latest stories

Related articles

Photo

Neurology

Supercomputer helps create 3D synthetic brain models

Scientists are using artificial intelligence (AI) and the Cambridge-1 supercomputer to synthesise artificial 3-D MRI images of human brains and create models that show disease states across various…

Photo

Antisense therapy update

Huntington's disease: setback for study of promising agent

Roche announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen (previously IONIS-HTTRx and RG6042) in manifest Huntington’s disease (HD). The decision was…

Photo

iPSC research

'Brain cell grafts' hold promise for reversing Parkinson’s symptoms

Grafting neurons grown from monkeys’ own cells into their brains relieved the debilitating movement and depression symptoms associated with Parkinson’s disease, researchers at the University of…

Related products

mediaire – mdbrain

Artificial Intelligence

mediaire – mdbrain

mediaire GmbH
Agfa - Smart XR

Accessories/ Complementary Systems

Agfa - Smart XR

Agfa HealthCare
Canon - Advanced Intelligent Clear-IQ Engine for CT

Artificial Intelligence

Canon - Advanced Intelligent Clear-IQ Engine for CT

Canon Medical Systems Europe B.V.
Canon – Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon – Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Canon - Aquilion Exceed LB

Oncology CT

Canon - Aquilion Exceed LB

Canon Medical Systems Europe B.V.
Canon - HIT Automation Platform

Artificial Intelligence

Canon - HIT Automation Platform

Canon Medical Systems Europe B.V.